News & Analysis on Clinical Trial Services & Contract Research And Development
Novartis has paid a US drug delivery company $10 million for an option to an oral formulation of an injectable drug used to treat osteoporosis that is currently the subject of litigation with Eli Lilly.
German drugmaker Bayer last week put an end to speculation that it is planning swingeing job cuts by conforming that it is planning to axe 560 positions in Germany and the US as part of restructuring its global pharmaceutical R&D operations.
In-Pharmatechnologist.com will be reporting this week from the Conference on Pharmaceutical Ingredients (CPhI) and in Brussels, Belgium, now in its 15th year and widely regarded as the premier event for the ingredient industry in Europe.
In-Pharmatechnologist's periodic round up of personnel moves in the industry includes a crop of new chief executives and senior managers across the pharmachem, drug development and manufacturing sectors.